首页> 美国卫生研究院文献>Bulletin of the New York Academy of Medicine >Non-prescription Syringe Sales in California: A Qualitative Examination of Practices among 12 Local Health Jurisdictions
【2h】

Non-prescription Syringe Sales in California: A Qualitative Examination of Practices among 12 Local Health Jurisdictions

机译:加利福尼亚州的非处方注射器销售:对12个地方卫生辖区中实践的定性检查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Legislation permitting non-prescription syringe sales (NPSS) was passed in 2004 in California as a structural intervention designed to expand access to syringes for injection drug users. As of December 2009, 19 of California’s 61 local health jurisdictions (LHJs) have approved policies to authorize pharmacies to sell non-prescription syringes. The legislation faces termination in 2010 if current evaluation efforts fail to demonstrate outcomes defined in the legislation. Using qualitative methods, we examined the systems and procedures associated with implementation; identified facilitators and barriers to implementation among 12 LHJs, and documented the role of public health in initiating and sustaining local programs. We identified consistent activities that led to policy implementation among LHJs and discovered several barriers that were associated with failure to implement local programs. Factors leading to NPSS were public health leadership; an inclusive planning process, marketing the program as a public health initiative; learning from others’ efforts, successes, and failures; and identifying acceptable syringe disposal options in advance of program implementation. Health departments that were confronted with political and moral arguments lost momentum and ultimately assigned a lower priority to the initiative citing the loss of powerful public health advocates or a lack of human resources. Additional barriers were law enforcement, elected officials, and pharmacy opposition, and failure to resolve syringe disposal options to the satisfaction of important stakeholders. The lessons learned in this study should provide useful guidance for the remaining LHJs in California without NPSS programs.
机译:加利福尼亚州于2004年通过了允许非处方注射器销售(NPSS)的立法,作为旨在扩大注射吸毒者使用注射器的结构性干预措施。截至2009年12月,加利福尼亚州的61个地方卫生辖区(LHJ)中有19个已批准政策,授权药房出售非处方注射器。如果当前的评估工作未能证明立法中定义的结果,则该立法将在2010年终止。使用定性方法,我们检查了与实施相关的系统和程序。确定了12个LHJ中促进实施的障碍和障碍,并记录了公共卫生在启动和维持地方计划中的作用。我们确定了导致LHJ实施政策的一致活动,并发现了与未能实施本地计划相关的几个障碍。导致NPSS的因素是公共卫生领导。包容性的计划过程,将该计划作为公共卫生计划进行营销;从他人的努力,成功和失败中学习;并在计划实施之前确定可接受的注射器处理选项。面对政治和道德争论的卫生部门失去了动力,并最终以缺乏强有力的公共卫生倡导者或缺乏人力资源为由,将该倡议的优先级降低。其他障碍包括执法,民选官员和药房反对派,以及未能解决注射器处置方案以使重要利益相关者满意的问题。在这项研究中吸取的教训应该为加利福尼亚州没有NPSS计划的其余LHJ提供有用的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号